• AAPL 174.431
  • TSLA 189.1
  • AMZN 181.495
  • MSFT 399.35
  • INTC 30.995
  • EURUSD 1.0714
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. STU /
  3. 1CG.STU

CRISPR Therapeutics AG (1CG STU) stock market data APIs

€40.8 0(0%) as of April 26, 2024

CRISPR Therapeutics AG Financial Data Overview

40.8
40.8
-
40.8
40.8
40.8-40.8
4 989 M
0
0
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '1CG',
Type: 'Common Stock',
Name: 'CRISPR Therapeutics AG',
Exchange: 'STU',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: 'CH0334081137',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: NULL,
Industry: NULL,
}

CRISPR Therapeutics AG Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get CRISPR Therapeutics AG Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get CRISPR Therapeutics AG End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get CRISPR Therapeutics AG latest news via APIs

CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

CRISPR Therapeutics AG ZUG, Switzerland and BOSTON, April 22, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based m...

CRISPR Therapeutics' (NASDAQ:CRSP) investors will be pleased with their favorable 63% return over the last five years

It might be of some concern to shareholders to see the CRISPR Therapeutics AG (NASDAQ:CRSP) share price down 17% in the last month. But at least the stock is up over the last five years. Unfortunately...
Do you have any questions?
support@eodhistoricaldata.com